Firm to use sale as springboard for growthElscint is ramping up its effort to penetrate the market for medicalimaging equipment in China. The Israeli vendor plans to use itssale of $23 million worth of equipment to China as a springboardto
Elscint is ramping up its effort to penetrate the market for medicalimaging equipment in China. The Israeli vendor plans to use itssale of $23 million worth of equipment to China as a springboardto increase its presence in the country, according to Dr. ThomasSpackman, president and CEO of Elscint's U.S. subsidiary.
Elscint Ltd. has identified China as one of two markets thecompany will target for growth in the coming years, the othermarket being the U.S., Spackman said.
"There will be a focus on the U.S. as one of the sophisticatedand mature marketplaces where we want to do business and Chinaas one of the major emerging markets," Spackman said. "This(order) is our kickoff in terms of the mainland Chinese market."
The deal includes MRI, CT and nuclear medicine systems (SCAN6/7/95). The order was arranged by Elscint's Hong Kong subsidiary,working in conjunction with a Chinese government ministry. Thesystems will be installed in hospitals run by the Chinese army,according to Spackman.
Some medical imaging companies operating in China have reporteddifficulties in receiving full payment for systems they've soldin the country, but Elscint does not expect any problems. Thesale is being financed by a line of credit issued to China InvestmentBank by Bank Hapoalim of Israel. The line of credit is backedby the Israeli government as part of its program to promote Israeliexports and support Third World development.
"The ultimate risk (for the loan) has been accepted bythe Israeli government," Spackman said. "We will beable to book the revenues by the end of this year."
The sale gives Elscint the critical mass needed to expand itssales, service and distribution operations in China. Elscint hasbegun setting up distributorships in the country and may establisha direct service organization. Elscint is also examining whetherto manufacture equipment in China, according to Spackman.
"We have begun to consider the possibility of doing somemanufacture or assembly or both in mainland China to solidifyour relationship with the Chinese market," Spackman said.
If it does set up a Chinese facility, Elscint will join Picker,GE, Siemens and Shimadzu as a medical imaging company with home-grownmanufacturing (SCAN 8/11/93 and 5/22/91). Most of those companiesbuild CT components in China.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.